Letter from C J Collins, Regulatory Affairs Manager at Armour Pharmaceutical Company Ltd to Dr M Duncan, Department of Health and Social Security. Concerns a letter requested by the DHSS from Armour in respect of the long term follow up of patients who received Batch Y69402 of Heat-Treated Factorate prior to the withdrawal of this product from the UK market.